Venomics AI Private Limited
PrivateLast Round
Early Funding
Apr 10, 2026
Total Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Venomics AI Private Limited is a biotechnology company that leverages AI and machine learning to analyze animal venoms for drug discovery and therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, NLP & Conversational AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Venomics AI Private Limited Comparables
Compare Venomics AI Private Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atheris Laboratories | 81% | |
| ProteinQure | 77% | |
| DeepSeq.AI, Inc. | 77% | |
Venomics AI Private Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 10, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
Raised $3M in early funding.
Venomics AI Private Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Venomics AI Private Limited's valuation, stock price, and market status.